You just read:

BerGenBio Presents Preliminary Clinical Data From Phase II Combination Trial of Bemcentinib and LDAC in Elderly AML Patients at ASH 2019

News provided by

BerGenBio ASA

09 Dec, 2019, 06:35 GMT